Statin Use and PSC

Dec 16, 2019 | Konstantinos N. Lazaridis, M.D. | @klazaridis
2019-01-21 Statins PSC
In a recent paper published in the journal Clinical Gastroenterology and Hepatology,  Stokkeland K. et al., reported the effects of exposure to medications on the outcomes of PSC using a population-based cohort of 2,914 patients from Sweden. The authors found that use of statins or azathioprine, among patients with PSC, was associated with reduced risk of all cause mortality, death or liver transplantation. Of note, exposure to ursodeoxycholic acid did not affect the mortality of these patients. Despite the retrospective nature of this study, these interesting findings suggest pursuing further investigation on the role of statins in the outcomes of PSC.

Interested in more newsfeed posts like this? Go to the Primary Sclerosing Cholangitis (PSC) blog.

Please sign in or register to post a reply.